Genotypic comparison of Pantoea agglomeransplant and clinical strains
Open Access
- 22 September 2009
- journal article
- research article
- Published by Springer Science and Business Media LLC in BMC Microbiology
- Vol. 9 (1), 204
- https://doi.org/10.1186/1471-2180-9-204
Abstract
Pantoea agglomerans strains are among the most promising biocontrol agents for a variety of bacterial and fungal plant diseases, particularly fire blight of apple and pear. However, commercial registration of P. agglomerans biocontrol products is hampered because this species is currently listed as a biosafety level 2 (BL2) organism due to clinical reports as an opportunistic human pathogen. This study compares plant-origin and clinical strains in a search for discriminating genotypic/phenotypic markers using multi-locus phylogenetic analysis and fluorescent amplified fragment length polymorphisms (fAFLP) fingerprinting. Majority of the clinical isolates from culture collections were found to be improperly designated as P. agglomerans after sequence analysis. The frequent taxonomic rearrangements underwent by the Enterobacter agglomerans/Erwinia herbicola complex may be a major problem in assessing clinical associations within P. agglomerans. In the P. agglomerans sensu stricto (in the stricter sense) group, there was no discrete clustering of clinical/biocontrol strains and no marker was identified that was uniquely associated to clinical strains. A putative biocontrol-specific fAFLP marker was identified only in biocontrol strains. The partial ORF located in this band corresponded to an ABC transporter that was found in all P. agglomerans strains. Taxonomic mischaracterization was identified as a major problem with P. agglomerans, and current techniques removed a majority of clinical strains from this species. Although clear discrimination between P. agglomerans plant and clinical strains was not obtained with phylogenetic analysis, a single marker characteristic of biocontrol strains was identified which may be of use in strain biosafety determinations. In addition, the lack of Koch's postulate fulfilment, rare retention of clinical strains for subsequent confirmation, and the polymicrobial nature of P. agglomerans clinical reports should be considered in biosafety assessment of beneficial strains in this species.Keywords
This publication has 59 references indexed in Scilit:
- Phylogeny and identification of Pantoea species associated with plants, humans and the natural environment based on multilocus sequence analysis (MLSA)Systematic and Applied Microbiology, 2008
- Isolation of Pseudomonas aeruginosa from Open Ocean and Comparison with Freshwater, Clinical, and Animal IsolatesMicrobial Ecology, 2007
- Pathogen aggressiveness and postharvest biocontrol efficiency in Pantoea agglomeransPostharvest Biology and Technology, 2006
- Osmotically induced trehalose and glycine betaine accumulation improves tolerance to desiccation, survival and efficacy of the postharvest biocontrol agentPantoea agglomeransEPS125FEMS Microbiology Letters, 2005
- Pantoea agglomerans pvs. gypsophilae and betae, recently evolved pathogens?Molecular Plant Pathology, 2003
- The Biosynthetic Gene Cluster of Pantocin A Provides Insights into Biosynthesis and a Tool for ScreeningAngewandte Chemie-International Edition, 2003
- Virulence factors of the human opportunistic pathogen Serratia marcescens identified by in vivo screeningThe EMBO Journal, 2003
- Pantocin B, an Antibiotic from Erwinia herbicola Discovered by Heterologous Expression of Cloned GenesJournal of the American Chemical Society, 1999
- CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choiceNucleic Acids Research, 1994
- Leclercia adecarboxylata Gen. Nov., Comb. Nov., formerly known asEscherichia adecarboxylata.Current Microbiology, 1986